Tokyo, March 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060798) titled 'Evaluation of the kukui nut oil (Aleurites moluccanus seed oil) for eyelash length in healthy adults' on March 2.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Non-randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - Mandom Corporation

Condition: Condition - Healthy Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - Despite its traditional application for hair growth in Polynesia, there is a paucity of scientific data regarding the impact of kukui nut oil (Aleurites moluccanus seed oil) on human eyelashes. This study investigates the effect of topical kukui nut oil application on eyelash elongation. Basic objectives2 - Safety,Efficacy

Intervention: Interventions/Control_1 - Right eyelash: Apply vehicle control to the eyelashes twice daily (morning and night) for 4 weeks. Interventions/Control_2 - Left eyelash: Apply 0.1% kukui nut oil to the eyelashes twice daily (morning and night) for 4 weeks.

Eligibility: Age-lower limit - 20 years-old = Gender - Female Key inclusion criteria - 1) Japanese women aged 20 to 49 at the time of consent acquisition 2) Individuals who perceive their eyelash length as average (neither extremely long nor extremely short) 3) Individuals who can agree not to use mascara, eyelash curlers, or false eyelashes during the trial period 4) Individuals who can agree not to undergo cosmetic procedures on their eyelashes, such as eyelash extensions or eyelash perms, during the trial period 5) Individuals not currently wearing false eyelashes, or who last wore false eyelashes at least 2 weeks prior 6) Individuals not currently wearing eyelash extensions, or who last had eyelash extensions applied at least 4 weeks prior Key exclusion criteria - 1) Individuals with permanent makeup applied to the eyeliner area 2) Individuals who are pregnant, may be pregnant, or are breastfeeding 3) Individuals who may exhibit allergic reactions to any component of the test product 4) Individuals participating in other clinical trials Target Size - 15

Recruitment Status: Recruitment status - Completed Date of protocol fixation - 2024 Year 11 Month 15 Day Date of IRB - 2024 Year 12 Month 04 Day Anticipated trial start date - 2025 Year 01 Month 07 Day Last follow-up date - 2025 Year 03 Month 07 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069545

Disclaimer: Curated by HT Syndication.